Zhilin Shen

Efficacy of Icotinib, an EGFR Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients with Exon 19 Deletion and Exon 21 L858R: A Retrospective Analysis in China

Hui Chen, Yongbin Ma, Yang Wang, 2021, Pharmacology.

Expression of PANDA, LincRNA-p21, PUMA in lung tissues of lung cancer patients in the Xuanwei and non-Xuanwei areas of Yunnan Province

Yu-jie Lei, Guang-qiang Zhao, Yunchao Huang, 2017 .

A fluorescent microsphere-based immunochromatographic strip is effective for quantitative fecal blood testing in colorectal cancer screening.

Xiyuan Sun, Qingbing Wang, Tianyuan Pan, 2022, American journal of translational research.

Ef fi cacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study

Ying Cheng, R. Guo, Yiping Zhang, 2022 .

Risk factors for developing high-output ileostomy in CRC patients: a retrospective study

Lei Li, Qingbing Wang, Zhilin Shen, 2021, BMC Surgery.

Risk factors for developing high-output ileostomy: a retrospective study

Lei Li, Qingbing Wang, Zhilin Shen, 2020 .

Decoding the Evolutionary Response to Ensartinib in ALK-Positive Non-Small-Cell Lung Cancer Patients by Dynamic Circulating Tumor DNA Sequencing.

W. Feng, Xiaoqing Liu, Yunpeng Liu, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

TNF-α augments CXCL10/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell

Xiang Xu, X. Ao, Zhengcheng Wang, 2021, International journal of biological sciences.

Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study

C. Liang, Kun Liu, Xiaoxin Li, 2023, Eye.

Efficacy and safety of befotertinib (D-0316) in patients with EGFR T790M mutated non-small cell lung cancer that had progressed after prior EGFR TKI therapy: A phase 2, multicenter, single-arm, open-label study.

Qingshan Li, Ying Cheng, R. Guo, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK‐positive NSCLC from a phase II study

W. Feng, K. Ma, G. Selvaggi, 2024, Cancer communications.